Biotech Accounting Manager: Clinical Trials & Close

Brave; San Francisco (CA); On-site; USD 125,000 - 145,000; Full time

Job summary

Braveheart Bio is a clinical-stage biopharmaceutical company advancing therapies for hypertrophic cardiomyopathy. The Accounting Manager will own day-to-day accounting operations, support month-end close, and prepare clinical accruals for a fast-moving biotech environment.

The role reports to the Senior Director, Controller, and partners with finance, clinical operations, and external vendors to scale the business while strengthening internal controls and financial reporting.

Qualifications

• 5+ years of progressive finance and accounting experience.
• Bachelor’s degree in accounting or related field.
• US GAAP knowledge including R&D accruals and clinical trial accounting.
• SOX/internal controls knowledge and cross-functional alignment.
• Public company audits experience with Big 4 or national firms.
• Strong communication and collaboration skills.

Responsibilities

• Support monthly close and FP&A budget-to-actual reporting.
• Review journal entries and reconciliations; mentor staff.
• Own clinical trial accruals with CROs and vendors.
• Implement policies and internal controls; streamline processes.
• Support audits, reviews, and system implementations.

Skills

5+ years finance

US GAAP knowledge

Excel proficiency

Public company audits

SOX internal controls

Cross-functional collaboration

Fast-paced environment

Ambiguity tolerance

Hands-on mindset

Big 4 audits experience

CPA preferred

NetSuite experience

Education

Bachelor’s degree in accounting or related field

Tools

NetSuite

Job description

Braveheart Bio is a clinical-stage biopharmaceutical company advancing therapies for hypertrophic cardiomyopathy. The Accounting Manager will own day-to-day accounting operations, support month-end close, and prepare clinical accruals for a fast-moving biotech environment.

The role reports to the Senior Director, Controller, and partners with finance, clinical operations, and external vendors to scale the business while strengthening internal controls and financial reporting.